Financials

Income Statement Balance Sheet Cash Flow Ratios

Quarterly (SAR)

1-5

	Q4 2025Dec 31, 2025	Q3 2025Sep 30, 2025	Q2 2025Jun 30, 2025	Q1 2025Mar 31, 2025	Q4 2024Dec 31, 2024
Operating Summary
Revenue	304.57M	342.31M	396.22M	457.53M	259.70M
Cost of Revenue	121.19M	133.77M	145.43M	164.68M	103.53M
Gross Profit	183.38M	208.54M	250.80M	292.85M	156.18M
SG&A	110.53M	90.86M	109.01M	122.15M	85.67M
R&D	10.86M	9.47M	8.98M	9.39M	9.28M
Operating Expenses	111.72M	98.61M	115.45M	134.66M	95.44M
Operating Income	71.66M	109.92M	135.35M	158.18M	60.74M
Interest Income	0.78M	0.99M	1.44M	1.42M	20.57M
Interest Expense	—	-0.35M	-0.30M	-0.03M	—
Other Income/Expense	-1.17M	—	—	-0.10M	-7.30M
Pretax Income	76.91M	113.34M	139.03M	163.81M	58.46M
Income Tax	8.84M	6.67M	7.01M	6.77M	6.86M
Net Income	68.07M	106.67M	132.02M	157.03M	51.61M
EBITDA	82.25M	120.95M	145.62M	168.29M	70.35M
EBIT	71.66M	109.92M	135.35M	158.18M	60.74M
EPS (Basic)	0.97	1.52	1.89	2.24	0.74
EPS (Diluted)	0.97	1.52	1.89	2.24	0.74
Margins & Efficiency
Gross Margin %	+60.2%	+60.9%	+63.3%	+64.0%	+60.1%
EBITDA Margin %	+27.0%	+35.3%	+36.8%	+36.8%	+27.1%
Net Margin %	+22.4%	+31.2%	+33.3%	+34.3%	+19.9%
Revenue & Income
Revenue	304.57M	342.31M	396.22M	457.53M	259.70M
Revenue Growth (YoY)	+17.3%	+4.5%	+14.6%	+18.7%	+24.3%
Interest & Investment Income	0.78M	0.99M	1.44M	1.42M	20.57M
Earnings From Equity Investments	4.54M	2.78M	2.55M	3.97M	7.73M
Gain (Loss) on Sale of Assets	—	—	—	—	—
Gain (Loss) on Sale of Investments	-0.10M	—	—	-0.03M	-4.52M
Currency Exchange Gain (Loss)	1.19M	—	—	0.40M	-18.75M
Expenses & Provisions
Cost of Revenue	121.19M	133.77M	145.43M	164.68M	103.53M
Selling, General & Admin	110.53M	90.86M	109.01M	122.15M	85.67M
Research & Development	10.86M	9.47M	8.98M	9.39M	9.28M
Operating Expenses	111.72M	98.61M	115.45M	134.66M	95.44M
Other Operating Expenses	-8.56M	-1.72M	-2.54M	3.13M	-10.90M
Interest Expense	—	-0.35M	-0.30M	-0.03M	—
Other Non Operating Income (Expenses)	-1.17M	—	—	-0.10M	-7.30M
Asset Writedown	—	—	—	—	—
D&A For EBITDA	10.59M	11.02M	10.27M	10.11M	9.61M
Profitability & Returns
Gross Profit	183.38M	208.54M	250.80M	292.85M	156.18M
Gross Margin	+60.2%	+60.9%	+63.3%	+64.0%	+60.1%
EBIT	71.66M	109.92M	135.35M	158.18M	60.74M
EBIT Margin	+23.5%	+32.1%	+34.2%	+34.6%	+23.4%
EBITDA	82.25M	120.95M	145.62M	168.29M	70.35M
EBITDA Margin	+27.0%	+35.3%	+36.8%	+36.8%	+27.1%
EBT Excluding Unusual Items	77.01M	113.34M	139.03M	163.84M	62.99M
Pretax Income	76.91M	113.34M	139.03M	163.81M	58.46M
Operating Income	71.66M	109.92M	135.35M	158.18M	60.74M
Operating Margin	+23.5%	+32.1%	+34.2%	+34.6%	+23.4%
Profit Margin	+22.4%	+31.2%	+33.3%	+34.3%	+19.9%
Net Income	68.07M	106.67M	132.02M	157.03M	51.61M
Net Income to Common	68.07M	106.67M	132.02M	157.03M	51.61M
Net Income Growth	+31.9%	+12.3%	+23.4%	+52.5%	+16.0%
Income Tax Expense	8.84M	6.67M	7.01M	6.77M	6.86M
Effective Tax Rate	+11.5%	+5.9%	+5.0%	+4.1%	+11.7%
Per Share & Capital
EPS (Basic)	0.97	1.52	1.89	2.24	0.74
EPS (Diluted)	0.97	1.52	1.89	2.24	0.74
EPS Growth	+31.9%	+12.3%	+23.5%	+52.5%	+16.0%
Dividend Per Share	2.00	—	2.00	—	1.46
Shares Change (YoY)	—	—	-0	—	—
Shares Outstanding (Basic)	70.00M	70.00M	69.85M	70.00M	70.00M
Shares Outstanding (Diluted)	70.00M	70.00M	69.85M	70.00M	70.00M
Dividend Growth	+37.0%	—	+25.0%	—	-2.7%
Free Cash Flow	184.83M	127.12M	55.45M	-14.14M	143.24M
Free Cash Flow Margin	+60.7%	+37.1%	+14.0%	-3.1%	+55.2%
Free Cash Flow Per Share	2.64	1.82	0.79	-0.20	2.05
Payout Ratio	—	+131.2%	—	+65.1%	—

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Quarterly (SAR)

1-5

	Q4 2025Dec 31, 2025	Q3 2025Sep 30, 2025	Q2 2025Jun 30, 2025	Q1 2025Mar 31, 2025	Q4 2024Dec 31, 2024
Operating Summary
Revenue	304.57M	342.31M	396.22M	457.53M	259.70M
Cost of Revenue	121.19M	133.77M	145.43M	164.68M	103.53M
Gross Profit	183.38M	208.54M	250.80M	292.85M	156.18M
SG&A	110.53M	90.86M	109.01M	122.15M	85.67M
R&D	10.86M	9.47M	8.98M	9.39M	9.28M
Operating Expenses	111.72M	98.61M	115.45M	134.66M	95.44M
Operating Income	71.66M	109.92M	135.35M	158.18M	60.74M
Interest Income	0.78M	0.99M	1.44M	1.42M	20.57M
Interest Expense	—	-0.35M	-0.30M	-0.03M	—
Other Income/Expense	-1.17M	—	—	-0.10M	-7.30M
Pretax Income	76.91M	113.34M	139.03M	163.81M	58.46M
Income Tax	8.84M	6.67M	7.01M	6.77M	6.86M
Net Income	68.07M	106.67M	132.02M	157.03M	51.61M
EBITDA	82.25M	120.95M	145.62M	168.29M	70.35M
EBIT	71.66M	109.92M	135.35M	158.18M	60.74M
EPS (Basic)	0.97	1.52	1.89	2.24	0.74
EPS (Diluted)	0.97	1.52	1.89	2.24	0.74
Margins & Efficiency
Gross Margin %	+60.2%	+60.9%	+63.3%	+64.0%	+60.1%
EBITDA Margin %	+27.0%	+35.3%	+36.8%	+36.8%	+27.1%
Net Margin %	+22.4%	+31.2%	+33.3%	+34.3%	+19.9%
Revenue & Income
Revenue	304.57M	342.31M	396.22M	457.53M	259.70M
Revenue Growth (YoY)	+17.3%	+4.5%	+14.6%	+18.7%	+24.3%
Interest & Investment Income	0.78M	0.99M	1.44M	1.42M	20.57M
Earnings From Equity Investments	4.54M	2.78M	2.55M	3.97M	7.73M
Gain (Loss) on Sale of Assets	—	—	—	—	—
Gain (Loss) on Sale of Investments	-0.10M	—	—	-0.03M	-4.52M
Currency Exchange Gain (Loss)	1.19M	—	—	0.40M	-18.75M
Expenses & Provisions
Cost of Revenue	121.19M	133.77M	145.43M	164.68M	103.53M
Selling, General & Admin	110.53M	90.86M	109.01M	122.15M	85.67M
Research & Development	10.86M	9.47M	8.98M	9.39M	9.28M
Operating Expenses	111.72M	98.61M	115.45M	134.66M	95.44M
Other Operating Expenses	-8.56M	-1.72M	-2.54M	3.13M	-10.90M
Interest Expense	—	-0.35M	-0.30M	-0.03M	—
Other Non Operating Income (Expenses)	-1.17M	—	—	-0.10M	-7.30M
Asset Writedown	—	—	—	—	—
D&A For EBITDA	10.59M	11.02M	10.27M	10.11M	9.61M
Profitability & Returns
Gross Profit	183.38M	208.54M	250.80M	292.85M	156.18M
Gross Margin	+60.2%	+60.9%	+63.3%	+64.0%	+60.1%
EBIT	71.66M	109.92M	135.35M	158.18M	60.74M
EBIT Margin	+23.5%	+32.1%	+34.2%	+34.6%	+23.4%
EBITDA	82.25M	120.95M	145.62M	168.29M	70.35M
EBITDA Margin	+27.0%	+35.3%	+36.8%	+36.8%	+27.1%
EBT Excluding Unusual Items	77.01M	113.34M	139.03M	163.84M	62.99M
Pretax Income	76.91M	113.34M	139.03M	163.81M	58.46M
Operating Income	71.66M	109.92M	135.35M	158.18M	60.74M
Operating Margin	+23.5%	+32.1%	+34.2%	+34.6%	+23.4%
Profit Margin	+22.4%	+31.2%	+33.3%	+34.3%	+19.9%
Net Income	68.07M	106.67M	132.02M	157.03M	51.61M
Net Income to Common	68.07M	106.67M	132.02M	157.03M	51.61M
Net Income Growth	+31.9%	+12.3%	+23.4%	+52.5%	+16.0%
Income Tax Expense	8.84M	6.67M	7.01M	6.77M	6.86M
Effective Tax Rate	+11.5%	+5.9%	+5.0%	+4.1%	+11.7%
Per Share & Capital
EPS (Basic)	0.97	1.52	1.89	2.24	0.74
EPS (Diluted)	0.97	1.52	1.89	2.24	0.74
EPS Growth	+31.9%	+12.3%	+23.5%	+52.5%	+16.0%
Dividend Per Share	2.00	—	2.00	—	1.46
Shares Change (YoY)	—	—	-0	—	—
Shares Outstanding (Basic)	70.00M	70.00M	69.85M	70.00M	70.00M
Shares Outstanding (Diluted)	70.00M	70.00M	69.85M	70.00M	70.00M
Dividend Growth	+37.0%	—	+25.0%	—	-2.7%
Free Cash Flow	184.83M	127.12M	55.45M	-14.14M	143.24M
Free Cash Flow Margin	+60.7%	+37.1%	+14.0%	-3.1%	+55.2%
Free Cash Flow Per Share	2.64	1.82	0.79	-0.20	2.05
Payout Ratio	—	+131.2%	—	+65.1%	—

Financials

Quarterly (SAR)

JAMJOOM PHARMA

Quarterly (SAR)